JO
AZN icon

John Overdeck’s AstraZeneca AZN Stock Holding History

John Overdeck’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$664K Sell
3,500
-2,500
-42% -$470K ﹤0.01% 3930
2026
Q1 		$1.18M Buy
+6,000
New +$1.16M ﹤0.01% 3134

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

John Overdeck's AZN Position: Q2 2026 in Review

John Overdeck increased its AstraZeneca (AZN) stake by 62% in Q2 2026, buying an estimated $23.7M and bringing the position to 329,087 shares worth $62.4M. The position accounts for 0.05% of the portfolio, ranked #466.

John Overdeck first reported a position in AZN in Q2 2013 and has held it in 42 quarters since. The position peaked at $216M in Q1 2024. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • John Overdeck held 329,087 shares of AstraZeneca worth $62.4M as of Q2 2026.
  • John Overdeck bought 126,061 AstraZeneca shares in Q2 2026, an estimated $23.7M.
  • AstraZeneca made up 0.05% of John Overdeck's portfolio in Q2 2026, its #466 holding.
  • John Overdeck first reported a position in AstraZeneca in Q2 2013 and has held it in 42 quarters since.
  • John Overdeck's AstraZeneca position peaked at $216M in Q1 2024.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.